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Attention-deficit hyperactivity disorder (ADHD) is a complex
polygenic disorder. This study aimed to discover common and
rare DNA variants associated with ADHD in a large homoge-
neous Han Chinese ADHD case–control sample. The sample
comprised 1,040 cases and 963 controls. All cases met DSM-IV
ADHD diagnostic criteria. We used the Affymetrix6.0 array to
assay both single nucleotide polymorphisms (SNPs) and copy
number variants (CNVs). Genome-wide association analyses
were performed using PLINK. SNP-heritability and SNP-genetic
correlations with ADHD in Caucasians were estimated with
genome-wide complex trait analysis (GCTA). Pathway analyses
were performed using the Interval enRICHment Test (INRICH),
the Disease Association Protein–Protein Link Evaluator (DAP-
PLE), and theGenomicRegionsEnrichment ofAnnotationsTool
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(GREAT). We did not find genome-wide significance for single
SNPs but did find an increased burden of large, rare CNVs in the
ADHDsample (P ¼ 0.038). SNP-heritabilitywas estimated tobe
0.42 (standard error, 0.13, P ¼ 0.0017) and the SNP-genetic
correlation with European Ancestry ADHD samples was 0.39
(SE 0.15, P ¼ 0.0072). The INRICH, DAPPLE, and GREAT
analyses implicated several gene ontology cellular components,
including neuron projections and synaptic components, which
are consistent with a neurodevelopmental pathophysiology for
ADHD. This study suggested the genetic architecture of ADHD
comprises both commonandrare variants. Somecommoncausal
variants are likely to be shared between Han Chinese
and Caucasians. Complex neurodevelopmental networks may
underlie ADHD’s etiology.  2013 Wiley Periodicals, Inc.
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INTRODUCTION
Attention-deficit hyperactivity disorder (ADHD) is a common
behavioral disorder of childhood, affecting 3–6% of school-age
children around the world [Faraone et al., 2003]. It has been viewed
as a polygenic, multifactorial disorder. Both common and rare
DNA variants contribute to its complex etiology [Poelmans
et al., 2011; Stergiakouli et al., 2012; Williams et al., 2012].
Genome-wide association studies (GWAS) are hypothesis-free,
interrogate all genes and regulatory regions of the genome and have
the potential to discover novel risk genes. ThefirstGWASofADHD
performed by Neale et al. [2008] analyzed 438,784 SNPs in 909
Caucasian ADHD trios. Although none of the SNP association tests
achieved genome-wide significance, the top-25 SNPs (based on
P-value) implicated some interesting candidate genes, including
cytoskeleton-organizer DCLK1, extracellular matrix component
SPOCK3, cell-cell adhesion protein CDH13, as well as two potassi-
um-channel regulators KCNIP1 and KCNIP4. Using the same
sample set, Lasky-Su et al. [2008] performed a quantitative ge-
nome-wide association analysis of ADHD symptoms. A high
percentage (30/32, 94%) genes hit by the 58 SNPs with P values
less than 105 were brain-expressed, including five related to
transcription factors.
Meanwhile, Lesch et al. [2008] used independent DNA pools
from343 ADHD-affected adults and 304 controls for association
analyses of the ADHD diagnostic phenotype. Of the 30 top-hit
genes, sevenwere involved in cell adhesion/migration/neurogenesis
(e.g., CDH13, ASTN2, CSMD2, ITGAE, ITGA11, CDH23, SDK2),
two regulated synaptic plasticity (e.g., CTNNA2, KALRN), three
were transcription factors (MYT1L, TFEB, SUPT3H), and one
coded for a potassium channel (KCNC1) [Lesch et al., 2008].
Neale et al. [2010a] performed case-control analyses in896 cases
with DSM-IV ADHD and 2,455 controls. A consensus dataset of
1,033,244 SNPs was imputed (using the HapMap Phase III Euro-
pean CEU and TSI samples as the reference). No genome-wide
significant associations were found. The most significant results
implicated PRKG1, FLNC, TCERG1L, PPM1H, NXPH1, CDH13,
HK1, and HKDC1. Combining data from four ADHD GWAS
projects, Neale et al. [2010b] performed ameta-analysis in a sample
of 2,064 trios, 896 cases, and 2,455 controls. Even with this much
larger sample size, no genome-wide significant associations were
found.One reason for this is that the sampleswereunderpowered to
estimate effect sizes of common variants of small effect. This has
been confirmed by analyses that estimate the variance contributed
by common variants all together. Genome-wide complex trait
analysis (GCTA) [Yang et al., 2010, 2011; Lee et al., 2011] applied
to ADHD samples (4,163 cases and 12, 040 controls) from the
Psychiatric Genomics Consortium, estimated SNP chip heritability
to be 0.28 (SE 0.02; Psychiatric GWAS Consortium ADHDGroup.
Paper submitted for publication).
Copy number variations (CNVs) have also been implicated in
the etiology of ADHD. Elia et al. [2010] found that inherited rare
CNVs in an ADHD sample were significantly enriched for genes
known to be important for psychological and neurological func-
tions, including learning, behavior, synaptic transmission, and
central nervous system development. Williams et al. [Williams
et al., 2010, 2012] found an increased burden of large, rare
CNVs and reported excess of chromosome 16p13.11 and
15q13.3duplications and an overlap between CNVs reported for
ADHD and autism spectrum disorders. Elia et al. [2012] further
showed that CNVs affecting the metabotropic glutamate receptor
genes GRM5, GRM7, GRM8, and GRM1were enriched across
several independent samples.
In summary, although ADHD is acknowledged to be a genetic
disorder, GWAS has not revealed any common SNP variants with
genome-wide significance. This study used both common and rare
variants, using polygenic and pathway analyses, to evaluate the
genetic etiology of ADHD in a large homogenous Han Chinese
case–control sample.
MATERIALS AND METHODS
Participants
One thousand and forty ADHD cases (876 boys, 84.2%) aged
between 6 and 16 years [average (9.7  2.4) years] were recruited
from the Child and Adolescent Psychiatric Outpatient Department
of the Sixth Hospital, Peking University. All cases met DSM-IV
ADHD diagnostic criteria. A clinical diagnosis was first made by a
senior child and adolescent psychiatrist based on the parent and
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teacher completed ADHD Rating Scale-IV (ADHD-RS-IV), and
then confirmed by semi-structured interview with the parents and
child using the Chinese version of the Clinical Diagnostic Interview
Scale [Barkley, 1998; Yang et al., 2004]. Those with major neuro-
logical disorders (e.g., epilepsy), schizophrenia, pervasive develop-
ment disorder, and mental retardation (IQ < 70) were excluded.
The sample consists of 680 (65.4%) ADHD combined type and 360
(34.6%) inattentive type. The comorbidities included oppositional
defiant disorder (ODD) in 380 patients (36.5%), conduct disorder
in 58 (5.6%), and tic disorder in 167 (16.1%).
Nine hundred sixty three controls were students from local
elementary schools, healthy blood donors from the Blood Center
of the First Hospital, Peking University, and healthy volunteers
from our institute. Six hundred and eight were males (63.1%). The
average age was (15.4  8.8) years. Parents or adults themselves
completed the ADHD Rating Scale-IV (ADHD RS-IV) to exclude
ADHD. Major psychiatric disorders, family history of psychosis,
severe physical diseases, and substance abuse were also excluded
according to a medical history report form. All the cases and
controls were of Han Chinese decent.
The studywas approved by the Institutional Review Board of the
Peking University Health Science Center. After complete descrip-
tion of the study to the subjects, written informed consent was
obtained from parents of the ADHD probands.
Genotyping
Both cases and controls were genotyped using the Affymetrix6.0
array at CapitalBio Ltd. (Beijing) using the standard Affymetrix
protocol. Samples of cases and controls were added in equal
proportion to each chip to avoid batch effects. The Affymetrix
6.0 array included 906,600 SNP probes and 946,000 CNV probes.
The SNP genotypes were called with BIRDSEED v2, while CNVs
were called with Genotyping Console (GTC) 4.0 using default
parameters. A total of 2003 cases and controls passed the first stage
sample control with call rates >98%, no first or second-degree
relative relationships, and genders consistent with site reports.
Data Quality Control and Statistical Analysis
Data quality control and association analysis were performed using
PLINK 1.07 [Purcell et al., 2007, http://pngu.mgh.harvard.edu/
purcell/plink/]. For inclusion of SNPs we required: call rate>95%,
MAF >1%, and HWE P-value >106. After data cleaning, there
were 656,051 SNPs for the association analyses. To examine popu-
lation stratification, we performed multi-dimensional scaling
(MDS). In the pair-wise MDS plot for 10 dimensions, the majority
of subjects were tightly clustered, suggesting no substantial popu-
lation stratification (SF1).We then conducted logistic regression to
adjust the association P-value, using the 10 principal components
from the MDS procedure as covariates.
CNV calling only included segments larger than 100 kb, span-
ning at least 10 consecutive, informative SNPs. Quality control for
samples excluded 136 individuals (71 cases, 65 controls) who
carried more than 40 apparent CNVs. Analysis focused on rare
CNVswith frequency<1%.Weused thehuman reference sequence
of NCBI Build 36.1 - hg18 to filter known segmental duplications.
Known common CNVs defined by the Genome Structural Varia-
tion Consortium (http://projects.tcag.ca/variation/ng42m_cnv.
php) and known gaps of at least 200 kb in the SNP array were
also filtered. Burden analysis counted the number of total CNVs,
deletions and duplications in cases and controls, calculated the
CNV rate, as well as percent of cases and controls that carried rare
CNVs. The significance of CNV differences between cases and
controls was assessed by permutation test with 50,000replicates.
Polygenic analyses. To investigate the contribution of com-
mon SNPs to variation in liability to ADHD,we estimated the SNP-
heritability using GCTA [Yang et al., 2011]. A non-zero heritability
is estimated if cases are genetically more similar to other cases than
they are to controls [Lee et al., 2011].We removed individuals such
that no pair had genetic similarity relationship >0.05 (as this may
inflate estimates unfairly), so that 1,010 cases and 917 controls
remained. We used Caucasian samples from the Psychiatric Geno-
mics Consortium for ADHD (4,163 ADHD cases and 12,040
controls) and a bivariate model of analysis [Lee et al., 2012b] to
estimate the SNP-genetic correlation between Han Chinese and
Caucasians for liability to ADHD. Since the SNP frequencies differ
between ethnic groups the additive genetic similarities between
individuals i and j were estimated as
Aij
1
L
XL
l¼1
ðxil  2pis;lÞ
xjl  2pis;lﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2pis;lqis;l2pjs;lqjs;l
p ði 6¼ jÞ
for the L SNPs with minor allele frequency >0.01and imputation
R2 > 0.6 (L ¼ 917,066), where i s represent a population that
individual i belong to and p and q ¼ 1  p are allele frequencies of
thefirst andother allele andxil is thenumber offirst alleles for the lth
SNP in individual i. The analysis model include sex, cohort and 20
ancestry principal components are covariates.
Pathway analysis. To determine if any neurobiological path-
ways were implicated by our association signals, we input our top
hit intervals from the SNP and CNV association analyses into
Interval enRICHment Test (INRICH [Lee et al., 2012a]). Associat-
ed intervals for SNPs included those with P-values <104 after
correcting for the MDS components. The SNP tagging function in
PLINKwasused to generate LD independent genomic intervals (tag
r2: 0.2, tag kb: 1,000). We included CNV intervals that were more
prevalent in cases than in controls with at least a trend difference
of statistical significance (P < 0.15). We used the Gene Ontology
(GO) nodes as our target gene sets. After size filtering, 5,237 target
gene sets (nodes) each comprising at least three genes were exam-
ined. Interval overlap was limited to 20 kb up/downstream of a
gene. The number of overlapping genes was recorded as Reali. Ten
thousand replicates generated random interval sets each matching
to the number of associated intervals. The empirical gene-set
P-value equals the percent of replicates with at least Reali number
of random intervals overlapping with genes in a target gene set.
Bootstrapping-based re-sampling was used for multiple testing to
correct the empirical gene-set P-value over all gene sets.
To explore potential physical interactions among proteins
encoded in associated intervals, we used a second method for
pathway analysis, that is, Disease Association Protein–Protein
Link Evaluator (DAPPLE) [Rossin et al., 2011]. In consideration
of the contributions of both common and rare variants to the
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etiology of ADHD, and that bothmight separately capture nodes in
the ADHD pathogenesis network, we used the same genomic
intervals for both SNPs and CNV that we used for INRICH.
DAPPLE uses experimentally validated, protein–protein interac-
tion databases to identify direct and indirect networks from asso-
ciated proteins and scores network and protein connectivity. We
built 10,000 randomnetworks and compared these with the ADHD
associated networks to determine if the connectivity of the ADHD
networks and each seed protein was greater than expected by
chance.
The third pathway analyses we used the Genomic Regions
Enrichment of Annotations Tool (GREAT, [McLean et al., 2010]
to assess for enrichment of cis-regulatory regions.GREATexamines
not only proximal but also distal regulatory regions up to 1 Mb
upstream or downstream of transcription start sites. In addition to
typical calculation of gene-based P-values for enrichment, GREAT
computes a binomial test over genomic regions, which uses the
fraction of the genome associated with each ontology term as the
probability of selecting the term. This method explicitly accounts
for the variability in length of gene regulatory domains, eliminating
the bias that leads to false positive enrichments for distal regulatory
regions.
RESULTS
Single Variant Analyses
The quantile-quantile (QQ) plot (SF2) for SNPs’ association was
almost completely diagonal. The lambda statistic (l) was 1.02.The
distribution of observed P-values did not deviate from the distri-
bution expected under the null hypothesis of no association. The
correctedManhattan plot is shown inSF3. The lowest P values were
about 105 to 106.The SNPs associated with P values of 105 or
lower are listed in Supplementary Table SI. All hit genes were
expressed in brain. Most of them were known to be involved in
neurodevelopment (including cell adhesion, neuron migration,
neurite outgrowth, neuronal morphogenesis, and synaptic plastic-
ity: ITGA1, NYAP2, ADAM28, CNTN2, LRFN2, NTM, GJA1,
FLRT2, PRKG1, PICK1, CAMK2G; glutamate receptor and trans-
porter: GRIK4, GRM7, SLC38A1; and related transcription factors:
PAPOLA, MED27, TAF2, ZNF516).
We included 3,460 rare CNVs (1,817 in cases and 1,643 in
controls) in the analyses, with all segments intersecting with one
or more genes (hg18). Burden analyses showed a significantly
higher rate of rare CNVs (1.875% vs. 1.830%, ratio: 1.02,
P ¼ 0.038) and proportion of individuals carrying rare CNVs
(55.8% vs. 51.2%, ratio: 1.09, P ¼ 0.026) for the ADHD group
than for controls. Association analyses found six regions nominally
associated with ADHD (P < 0.05, with 50,000 permutation tests),
though none of them survived genome-wide correction (Supple-
mentary Table SII).
Polygenic Analyses
The estimate of the SNP-heritability calculated in the bivariate
analysiswas 0.42 (SE0.13) for theHanChinese sample (h2SNPHC).A
maximum likelihood ratio test of H0: h2SNP ¼ 0 is P ¼ 0.0017. In
thebivariate analysis the SNP-heritability for theEuropean ancestry
sample (h2SNPEA) was 0.28 (SE 0.02, P ¼ 0), in close agreement
(as expected) with the univariate estimate PGC Cross Disorder
Group, paper in submission. The estimate of the SNP-genetic
correlation between Chinese and European samples (rg-SNP) was
0.39 (SE 0.15, P ¼ 0.0072).
Pathway Analyses
Interval enrichment tests of the most significantly associated SNPs
found 23 pathways enriched for associated signals (Table I). Al-
though none of these achieved significance after correcting for
multiple comparisons, many implicated neurobiological functions
potentially relevant to ADHD, e.g. neuron projection morphogen-
esis (ITGA1, GJA1), neuron migration (PRKG1, GJA1), endocytic
vesicle membrane (PICK1, CAMK2G), synaptic transmission
(PICK1, CAMK2G, SLC38A1, GRM7). Pathways related to tran-
scription were observed, that is, transcription initiation from RNA
polymerase II promoter (MED27, TAF2). Interval enrichment tests
of CNVs found 9 pathway nominal significant at P < 0.05. None
achieved significance after correcting for multiple comparisons
(Table I).Mostwere related to transmembrane transport, including
water, sodium and potassium ion transport.
DAPPLE identified 16 direct connections among proteins in 152
associatedregions(Table II).Comparedto10,000randomnetworks,
the associated network (SF4) is significantly enriched for direct
connectivity(16 vs. 9.7, P ¼ 0.030).The connected proteins formed
six groups. Their functions involved cell adhesion/synaptic forma-
tion/plasticity, especially forglutamatergic synapticplasticity, aswell
as related transcription factors. For each seedprotein, taking the best
of thedirect and indirect scoresandcorrecting forthenumberof tests
as well as for the number of genes in one locus, we identified seven
genes significant for connectivity to be candidate genes for future
research: NCL (P ¼ 2  104), KCNH7 (P ¼ 8  104), NXPH1
(1  103), LANCL1 (6  103), CNTNAP2 (9  103), SV2C
(1.2  102), and PICK1 (4  102).
Using the same set of associated SNPs and CNVs for GREAT
analyses, we found significant enrichment for 6 GO Cellular
Component terms after correcting for multiple comparisons
(Table III). The six terms were from two GO branches and
their child nodes (Fig. 1): synapse (15 genes hit, FDR Q-val:
0.0055; three child nodes were also significant: synapse part,
synaptic membrane, and presynaptic membrane) and neuron
projection (16 genes hit, FDR Q-val: 0.013; one child node was
also significant: axon).
DISCUSSION
This GWAS of ADHD, comprising 1,040 cases and 963 controls, is
the first performed in a homogeneous Han Chinese population.
Althoughwedidnotfindany genome-wide significant SNPorCNV
variants, we did find significant evidence for a polygenic SNP
component and an increased burden of rare CNVs.
The significant SNP-heritability implies that common variants
are associated with ADHD, but that our sample is underpowered to
detect them at the stringent significance level imposed by the
genome-wide burden of multiple testing. The SNP-heritability in
Han Chinese was 0.42 (SE 0.15). Although the point estimate is
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higher than for the larger European ancestry sample from the PGC-
ADHD, 0.28 (SE 0.02), its high standard error shows that the
estimates are not significantly different. The estimate of the
SNP-genetic correlation (rg-SNP) was 0.39 (SE 0.15, P ¼ 0.0072),
which indicates that common SNP risk variants are shared by the
Han Chinese and European Ancestry samples. To our knowledge,
this is the first such correlation reported for any disease or disorder.
The significant correlation indicates that ancient common variants
associated with ADHD are shared between the ethnic groups.
However, the point estimate of the SNP correlation between
HanChinese andEuropeanAncestry samples is lower than between
sub-samples of the European Ancestry cohort. Specifically, when
the PGC-ADHD data was split into two sub-samples, the h2SNPEA
estimates were 0.21 (SE 0.07) for the first sample and 0.41 (SE 0.03)
for the other sample with a genetic correlation of 0.71 (SE 0.17)
implying, as expected, more sharing of associated variants and/or
higher linkage disequilibrium between causal variants and SNPs
within than between ethnic populations.
TABLE I. Pathways Enriched for Associated SNPs and CNVs by INRICH Test
Target
Target
size
Interval
no. Emp. P Cor. P Gene list
Pathways enriched for associated SNPsa
GO: 0009268Response_to_pH 12 2 0.00009999 0.14917 ARSB, GJA1
GO: 0043403Skeletal_muscle_tissue_regeneration 9 2 0.00019998 0.192162 PLAU, GJA1
GO: 0048812Neuron_projection_morphogenesis 18 2 0.00029997 0.231354 ITGA1, GJA1
GO: 0007160Cell-matrix_adhesion 72 3 0.00049995 0.295941 VCL, ITGA1, BCL2L11
GO: 0005916Fascia_adherens 9 2 0.00079992 0.378724 VCL, GJA1
GO: 0006936Muscle_contraction 93 3 0.00109989 0.447111 VCL, ITGA1, GJA1
GO: 0030666Endocytic_vesicle_membrane 24 2 0.00269973 0.661668 PICK1, CAMK2G
GO: 0006367Transcription_initiation_from_RNA_polymerase_II_promoter 67 2 0.00379962 0.727854 MED27, TAF2
GO: 0005741Mitochondrial_outer_membrane 85 2 0.00679932 0.847231 GJA1, BCL2L11
GO: 0007229Integrin-mediated_signaling_pathway 58 2 0.010399 0.894421 ITGA1, ADAMDEC1
GO: 0005178Integrin_binding 64 2 0.0114989 0.907419 ITGA1, ADAMDEC1
GO: 0007268Synaptic_transmission 266 4 0.0121988 0.915217 PICK1, CAMK2G,
SLC38A1, GRM7
GO: 0005764Lysosome 154 2 0.0157984 0.946011 ARSB, GJA1
GO: 0030165PDZ_domain_binding 54 2 0.019898 0.965807 GRM7, GJA1
GO: 0015293Symporter_activity 112 2 0.019898 0.965807 SLC38A1, SLC16A8
GO: 0005624Membrane_fraction 467 4 0.0243976 0.982004 ITGA1, SLC16A8, PSD3,
BCL2L11
GO: 0001764Neuron_migration 59 2 0.0255974 0.983003 PRKG1, GJA1
GO: 0045121Membrane_raft 110 2 0.0256974 0.983203 ITGA1, GJA1
GO: 0006814Sodium_ion_transport 118 2 0.0265973 0.984003 SLC38A1, SCN9A
GO: 0005654Nucleoplasm 732 4 0.0214979 0.968806 MED27, CAMK2G, DSCC1,
PAPOLA
GO: 0017124SH3_domain_binding 101 2 0.0357964 0.992402 BAIAP2L2, GJA1
GO: 0043234Protein_complex 152 2 0.0437956 0.995601 PICK1, VCL
GO: 0001701In_utero_embryonic_development 142 2 0.0459954 0.996601 GJA1, BCL2L11
Pathways enriched for associated CNVsb
GO: 0006833Water_transport 36 2 0.00549945 0.508498 AQP9, ADCY8
GO:0005244 Voltage-gated_ion_channel_activity 149 4 0.0115988 0.734653 KCNH7, KCNQ1, SCN10A,
SCN11A
GO: 0055085Transmembrane_transport 619 6 0.0125975 0.752849 KCNH7, SCN10A, KCNQ1, AQP9,
ADCY8, SCN11A
GO: 0042493Response_to_drug 241 3 0.0164984 0.834233 USP47, CPS1, SCN11A
GO:0005248 Voltage-gated_sodium_channel_activity 15 2 0.0172983 0.84883 SCN10A, SCN11A
GO:0001518 Voltage-gated_sodium_channel_complex 12 2 0.0172983 0.84883 SCN10A, SCN11A
GO:0006814Sodium_ion_transport 118 2 0.0258974 0.909018 SCN10A, SCN11A
GO:0006811 Ion_transport 565 5 0.030397 0.928814 KCNH7, KCNQ1, KCNT2, SCN10A,
SCN11A
GO: 0006813Potassium_ion_transport 153 3 0.0392961 0.956809 KCNH7, KCNQ1, KCNT2
aWith corrected P-value <10e4.
bIncluding CNVs more in cases than in controls with P < 0.15.
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Despite the fact that no individual SNPs reached association at
genome-wide significance, ourmost significant findings implicated
genes participating in neurodevelopmental processes such as cell
adhesion, neuron migration, neurite outgrowth, neuronal mor-
phogenesis, and synaptic plasticity. Similar sets of genes were also
suggested by previous ADHD GWAS and a meta-analysis (see
Supplementary Table SI). For example, PRKG1 was implicated by
Neale et al. [2010a], ITGA1, CAMK2G, CAMK1Dwere implicated
in the meta-analysis by Neale et al. [2010b], and ITGAE and
ITGA11 were implicated by Lesch et al. [2008]. Some of our top
genes code for glutamate receptors and transporters. The same
genes and gene family members (GRM7, GRIK1) were reported in
the quantitative GWAS by Lasky-Su et al. [2008], themeta-analysis
by Neale et al. [2010b], and the genome-wide CNV study by
Elia et al. [2012]. Some genes related to transcription (ZNF544,
ZNF385D, ZNF423, ZNF516, ZNF75A, DMRT2, FHIT, FOXP1,
and MEIS2) were also implicated by Lasky-Su et al. [2008] and by
Neale et al. [2010b]’s meta-analysis.
Although not significant after correcting for multiple compar-
isons, the pathways revealed by the INRICH analyses of associated
SNPs involved neurobiological functions consistent with the prior
findings discussed above. For example, neuron projection mor-
phogenesis and neuron migration pathways were implicated by
genes encoding adhesion molecules (e.g., GJA1, ITGA1, PRKG1).
Neuron migration and axon guidance toward the target in the
development of the nervous system involve interactions between
molecules on the surface of the axon and those in the extra-cellular
matrix [Tsiotra et al., 1993]. The endocytic vesicle membrane and
synaptic transmission pathways involve glutamatergic synaptic
function. The transcription related pathway is a ubiquitous bio-
logical process, if, as our findings suggest, it is implicated in
ADHD’s pathophysiology, any defects in the implicated transcrip-
tion network must require other etiological factors to lead to a
pathophysiologic state.
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FIG. 1. Neurodevelopmental network predicted by proximal and
distal regulatory region among the top hit of genome-wide SNPs
and CNVs association.
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Because the GO “pathways” used by INRICH are based on
bibliometric gene annotations rather than experimental data, we
also used DAPPLE, which is based only on experimentally docu-
mented physical interactions among proteins. Considering the
complexity of the genetic basis of ADHD, we hypothesized that
both common and rare variants contribute to the disorder and act
on similar functional classes of genes [Poelmans et al., 2011; Ster-
giakouli et al., 2012]. The DAPPLE analyses showed that the
proteins implicated by our GWAS were significantly more likely
to be interconnected with one another than expected by chance,
suggesting that risk variants might exist in suites of genes involved
in the underlying biological process of protein-protein interaction
networks. The DAPPLE results are consistent with the INRICH
results implicating threepathways: cell adhesion (NXPH1–NRXN1,
CNTN2–CNTNAP2–ZMIZ1), glutamate synaptic development
(GRM7–PICK1–GRM3, PICK1–EPHA7), and the transcription
pathway (TAF2–PAPOLA–POLR2F–MED27–MED20, POLR2F–
NCL–RSL1D1–BYSL).
Using the regulatory annotation of associated signals, GREAT
depicted a clearer outline of associated genes, which encoded
proteins comprising neuronal cellular components from the Neu-
ron Projection and Synapse branches of the GO tree. Most of the
genes from these pathways were consistent with the INRICH and
DAPPLE findings; they encode adhesion molecules, glutamate
receptors and proteins involved in axon and synapse development
(Supplementary Table SIII).
All the above pathways are consistent with the hypothesis that
mis-wiring of the brain during neurodevelopment might cause
ADHD. Similar conclusions were drawn by Lesch et al. [2008]
and Franke et al. [2009] based on the findings from existing
GWAS, which suggested that neuronal spine formation and
plasticity might underlie the pathophysiology of ADHD. Con-
sistent with these ideas, a recent integration of ADHD GWAS
findings found significant evidence for a neurodevelopmental
network of directed neurite outgrowth [Poelmans et al., 2011].
Although our findings are consistent with prior work, they also
provide evidence for a more comprehensive network, involving
neuron migration, neurite outgrowth, neuronal morphogenesis,
and synaptic plasticity, especially glutamatergic synaptic devel-
opment. The glutamate system is a reasonable candidate for
ADHD’s pathophysiology as glutamate is the major excitatory
neurotransmitter in the central nervous system, and regulates the
catecholaminergic activity which has been implicated in ADHD
by neurobiological [Scassellati et al., 2012] and treatment [Far-
aone and Glatt, 2010] studies.
Although our findings are intriguing, we have only captured
fragments of the puzzle of ADHD’s etiology in this study.We could
not paint the full picture. Our work must be considered in the
context of its limitations. We had no genome-wide significant
findings for any single variant, which might be due to the sample
size.However, our bioinformatic andpathway analyses found some
interesting genes and neurobiological pathways which implicate
complex neurodevelopmental network underlying ADHD. Our
finding of a significant polygenic component suggests that there
aremany common SNP variants with small effect sizes that increase
the risk for ADHD. Individually, these SNPs will be difficult to
detect with currently available sample sizes.
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